Bulletin
Investor Alert

Intellia Therapeutics Inc.

NAS: NTLA

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Jun 24, 2022, 7:58 p.m.

/zigman2/quotes/207821052/composite

$

53.40

Change

-0.01 -0.02%

Volume

Volume 633,882

Quotes are delayed by 20 min

/zigman2/quotes/207821052/composite

Previous close

$ 50.76

$ 53.41

Change

+2.65 +5.22%

Day low

Day high

$49.30

$55.23

Open

52 week low

52 week high

$37.08

$202.73

Open

Muna Bhanji

Founder of TIBA Global Access LLC, Muna Bhanji presently is President at this company and Senior Advisor at Arsenal Capital Management LP. Ms. Bhanji is also on the board of 5 other companies.

Ms. Bhanji previously was Senior VP-Global Market Access & Policy at Merck & Co., Inc.

Ms. Bhanji received an MBA from St. Joseph's University and an undergraduate degree from Ernest Mario School of Pharmacy.

Transactions

Date Shares Transaction Value
06/14/2022 2,014   Award at $0 per share. 0
04/28/2022 7,954   Award at $0 per share. 0

Officers and Executives

Dr. John M. Leonard
President, Chief Executive Officer & Director
Mr. Glenn Goddard
Treasurer, Chief Financial & Accounting Officer
Dr. Laura Sepp-Lorenzino
Chief Scientific Officer & Executive VP
Dr. Eliana Clark
Chief Technology Officer & Executive VP
Dr. David Lebwohl
Chief Medical Officer & Executive Vice President
Dr. Christine Foster
SVP-Business Development & Alliance Management
Mr. Derek Hicks
Chief Business Officer & Executive Vice President
Mr. Ian Karp
Senior Vice President-Corporate Communications
Ms. Marika St Amand
Chief Human Resources Officer
Mr. James Basta
Secretary, Executive VP & General Counsel
Dr. Frank A. G. M. Verwiel
Chairman
Mr. John Francis Crowley
Independent Director
Dr. Georgia Keresty
Independent Director
Ms. Muna Bhanji
Independent Director
Dr. Jean-Francois B. Formela
Independent Director
Ms. Caroline D. Dorsa
Independent Director
Dr. Jesse L. Goodman
Independent Director
Dr. Fred Ehrenkranz Cohen
Independent Director
Link to MarketWatch's Slice.